PTGX

Latest SEC Filings & News for PTGX

2 most recent filings and news items mentioning PTGX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/PTGX/news?limit=20"

Pull PTGX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
Trading IdeasJun 22, 2026Neutral

AbbVie Expands Immunology Footprint With Apogee $11 Billion Acquisition

AbbVie Expands Immunology Footprint With Apogee $11 Billion Acquisition

View filing at SEC.gov →
OtherJun 18, 2026Neutral

Protagonist Therapeutics adopts 2026 Equity Incentive Plan

Protagonist Therapeutics' board adopted and stockholders approved a new 2026 Equity Incentive Plan on June 17, 2026, succeeding the prior 2016 plan. The new plan expands share reserves and provides equity awards to employees, directors, and consultants to retain talent and align

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.